European Commission approves AbbVie’s RINVOQ (upadacitinib)
AbbVie said the European Commission approved RINVOQ (upadacitinib).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.